U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07558564) titled 'Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies' on April 23.
Brief Summary: This multicenter, prospective, observational study, based on real-world evidence (RWE), aims to evaluate the efficacy and safety of Platelet-Rich Plasma (PRP) treatment across four types of tendinopathies: patellar, Achilles, epicondylar, and plantar fasciosis. Data collection and analysis will be conducted using the BioSmartData(R) platform, including hematology analyzers for PRP characterization, clinical variables, treatment protocols, and longitudinal assessment of therapeutic response.
Study Start Date: April, 2026
Study Type: OBSE...